<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Differences in clinical features between myotonic dystrophy type 1 and type 2</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Differences in clinical features between myotonic dystrophy type 1 and type 2</h1>
<div class="graphic"><div class="figure"><div class="ttl">Differences in clinical features between myotonic dystrophy type 1 and type 2</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33.3%"></colgroup> <tbody> <tr> <td class="subtitle1">Â </td> <td class="subtitle1">Adult-onset myotonic dystrophy type 1</td> <td class="subtitle1">Myotonic dystrophy type 2</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Genetics</td> </tr> <tr> <td class="indent1">Inheritance</td> <td>Autosomal dominant</td> <td>Autosomal dominant</td> </tr> <tr> <td class="indent1">Anticipation</td> <td>Pronounced</td> <td>Exceptionally rare</td> </tr> <tr> <td class="indent1">Congenital form</td> <td>Yes</td> <td>No</td> </tr> <tr> <td class="indent1">Chromosome</td> <td>19q13.3</td> <td>3q21.3</td> </tr> <tr> <td class="indent1">Locus</td> <td><em>DMPK</em></td> <td><em>CNBP</em></td> </tr> <tr> <td class="indent1">Expansion mutation</td> <td>(CTG)<sun>n</sun></td> <td>(CCTG)<sun>n</sun></td> </tr> <tr class="divider_bottom"> <td class="indent1">Location of the expansion</td> <td>3' untranslated region</td> <td>Intron 1</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Core features</td> </tr> <tr> <td class="indent1">Clinical myotonia</td> <td>Typical in adult onset</td> <td>Present in less than 50%</td> </tr> <tr> <td class="indent1">Myotonia on electromyography</td> <td>Generally present</td> <td>Absent and variable in many patients; needs detailed investigation</td> </tr> <tr> <td class="indent1">Muscle weakness</td> <td>Disability often by age 30 to 50 years</td> <td>Disability at age 60 to 85 years</td> </tr> <tr class="divider_bottom"> <td class="indent1">Cataracts</td> <td>Generally present</td> <td>Present in a few patients at diagnosis</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Localization of muscle weakness</td> </tr> <tr> <td class="indent1">Face or jaw</td> <td>Generally present</td> <td>Usually absent</td> </tr> <tr> <td class="indent2">Ptosis</td> <td>Often present</td> <td>Rare, mild, or moderate</td> </tr> <tr> <td class="indent1">Bulbar (dysphagia)</td> <td>Generally present later in life</td> <td>Not present</td> </tr> <tr> <td class="indent1">Respiratory muscles</td> <td>Generally present later in life</td> <td>Exceptionally rare cases</td> </tr> <tr> <td class="indent1">Distal limb muscle</td> <td>Generally prominent</td> <td>Flexor digitorum profundus in some patients</td> </tr> <tr> <td class="indent1">Proximal limb muscle</td> <td>Can be absent for many years</td> <td>Main disability in most patients, late onset</td> </tr> <tr class="divider_bottom"> <td class="indent1">Sternocleidomastoid muscle</td> <td>Generally prominent</td> <td>Prominent in few patients</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Muscular symptoms</td> </tr> <tr> <td class="indent1">Myalgic pain</td> <td>Absent or moderate</td> <td>Most disabling symptom in many patients</td> </tr> <tr> <td class="indent1">Muscle strength variations</td> <td>Occasional</td> <td>Can be considerable</td> </tr> <tr> <td class="indent1">Visible muscle atrophy</td> <td>Face, temporal, distal hands, and legs</td> <td>Usually absent</td> </tr> <tr class="divider_bottom"> <td class="indent1">Calf hypertrophy</td> <td>Absent</td> <td>Present in at least 50%</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Laboratory findings</td> </tr> <tr class="divider_bottom"> <td class="indent1">Concentration of creatine kinase in serum</td> <td>Normal-to-moderate increase</td> <td>Normal-to-moderate increase</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Muscluar biopsy findings</td> </tr> <tr> <td class="indent1">Fiber atrophy</td> <td>Smallness of type 1 fibers</td> <td>Highly atrophic type 2 fibers</td> </tr> <tr> <td class="indent1">Nuclear clump fibers</td> <td>In late stage only</td> <td>Scattered early before weakness</td> </tr> <tr> <td class="indent1">Sarcoplasmic masses</td> <td>Very frequent in distal muscles</td> <td>Very rare</td> </tr> <tr> <td class="indent1">Ring fibers</td> <td>Frequent</td> <td>May occur</td> </tr> <tr class="divider_bottom"> <td class="indent1">Internal nuclei</td> <td>Massive in distal muscle</td> <td>Variable and mainly in type 2 fibers</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Cardiac symptoms</td> </tr> <tr class="divider_bottom"> <td class="indent1">Conduction defects</td> <td>Common</td> <td>Highly variable, absent to severe</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Other neurological symptoms</td> </tr> <tr> <td class="indent1">Tremors</td> <td>Absent</td> <td>Prominent in many patients</td> </tr> <tr> <td class="indent1">Behavioral changes</td> <td>Common</td> <td>Not apparent</td> </tr> <tr class="divider_bottom"> <td class="indent1">Hypersomnia</td> <td>Prominent</td> <td>Infrequent</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Other features</td> </tr> <tr> <td class="indent1">Manifest diabetes</td> <td>Occasional</td> <td>Infrequent</td> </tr> <tr> <td class="indent1">Frontal balding in men</td> <td>Generally present</td> <td>Exceptional</td> </tr> <tr> <td class="indent1">Incapacity (work and activities of daily living)</td> <td>Typically after age 30 to 35 years</td> <td>Rarely younger than 60 years, unless severe pain</td> </tr> <tr> <td class="indent1">Life expectancy</td> <td>Reduced</td> <td>Normal</td> </tr> </tbody></table></div><div class="graphic_reference">Originally published in Acta Neuropathologica, Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2, Vol. 119, 2010, p. 465, Vihola A, Bachinski LL, Sirito M, et al, Â© Springer-Verlag 2010. Modified with permission of Springer. Reproduced from: Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 2012; 11:891. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 70688 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
